‘GPS nanoparticle’ platform precisely delivers therapeutic payload to cancer cells

Date posted
Funding Agency
(Funded by the U.S. Department of Defense and the National Science Foundation)

Researchers from Pennsylvania State University have developed a "GPS nanoparticle" that, after being injected intravenously, can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread. The researchers showed that this nanoparticle works for basal-like breast cancers, which are characterized by aggressive, quickly growing tumors that shed cancer cells, which then spread elsewhere in the body.

Keywords